OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Cited by CrossRef (14)

  1. Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología 2020;43:526
    https://doi.org/10.1016/j.gastrohep.2020.03.017
  2. Kyoko Yoshida, Alice Desbiolles, Sarah F. Feldman, Sang Hoon Ahn, Enagnon K. Alidjinou, Masanori Atsukawa, Laurence Bocket, Maurizia R. Brunetto, Maria Buti, Ivana Carey, Gian Paolo Caviglia, En-Qiang Chen, Markus Cornberg, Masaru Enomoto, Masao Honda, Christoph Höner Zu Siederdissen, Masatoshi Ishigami, Harry L.A. Janssen, Benjamin Maasoumy, Takeshi Matsui, Akihiro Matsumoto, Shuhei Nishiguchi, Mar Riveiro-Barciela, Akinobu Takaki, Pisit Tangkijvanich, Hidenori Toyoda, Margo J.H. van Campenhout, Bo Wang, Lai Wei, Hwai-I Yang, Yoshihiko Yano, Hiroshi Yatsuhashi, Man-Fung Yuen, Eiji Tanaka, Maud Lemoine, Yasuhito Tanaka, Yusuke Shimakawa. Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants. Clinical Gastroenterology and Hepatology 2021;19:46
    https://doi.org/10.1016/j.cgh.2020.04.045
  3. Maurizia R. Brunetto, Ivana Carey, Benjamin Maasoumy, Cristina Marcos‐Fosch, André Boonstra, Gian Paolo Caviglia, Alessandro Loglio, Daniela Cavallone, Caroline Scholtes, Gabriele Ricco, Antonina Smedile, Mar Riveiro‐Barciela, Florian van Bömmel, Annemiek van der Eijk, Fabien Zoulim, Thomas Berg, Markus Cornberg, Pietro Lampertico, Kosh Agarwal, Maria Buti. Incremental value of HBcrAg to classify 1582 HBeAg‐negative individuals in chronic infection without liver disease or hepatitis. Aliment Pharmacol Ther 2021;53:733
    https://doi.org/10.1111/apt.16258
  4. Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan-ping Liu, Dan Huang, Yan-ling Feng. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients. Gastroenterología y Hepatología (English Edition) 2020;43:526
    https://doi.org/10.1016/j.gastre.2020.03.005
  5. Zhanqing Zhang, Wei Lu, Dong Zeng, Dan Huang, Weijia Lin, Li Yan, Yanling Feng. Quantitative HBsAg versus HBV DNA in Predicting Significant Hepatitis Activity of HBeAg-Positive Chronic HBV Infection. JCM 2021;10:5617
    https://doi.org/10.3390/jcm10235617
  6. Guichan Liao, Xia Ding, Muye Xia, Yin Wu, Hongjie Chen, Rong Fan, Xiaoyong Zhang, Shaohang Cai, Jie Peng. Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B. IJGM 2021;Volume 14:4967
    https://doi.org/10.2147/IJGM.S321253
  7. Zhanqing Zhang, Wei Lu, Dan Huang, Xinlan Zhou, Rongrong Ding, Xiufen Li, Yanbing Wang, Weijia Lin, Dong Zeng, Yanling Feng. Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection. Front. Immunol. 2022;13
    https://doi.org/10.3389/fimmu.2022.944097
  8. Zhan-qing Zhang, Bi-sheng Shi, Wei Lu, Dan Huang, Yan-bing Wang, Yan-ling Feng. Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection. Journal of Virological Methods 2021;296:114226
    https://doi.org/10.1016/j.jviromet.2021.114226
  9. Celina Adraneda, Yong Chuan Tan, Ee Jin Yeo, Guan Sen Kew, Atefeh Khakpoor, Seng Gee Lim. A critique and systematic review of the clinical utility of hepatitis B core-related antigen. Journal of Hepatology 2023;78:731
    https://doi.org/10.1016/j.jhep.2022.12.017
  10. Angelo ARMANDI, Chiara ROSSO, Davide G. RIBALDONE, Gian P. CAVIGLIA. Moving towards core antigen for the management of patients with overt and occult HBV infection. Panminerva Med 2021;63
    https://doi.org/10.23736/S0031-0808.20.04163-4
  11. Mehmet Koroglu, Muhammed Ali Ayvaz, Suat Baran Bakan, Abdullatif Sirin, Umit Akyuz. Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?. 2024;36:489
    https://doi.org/10.1097/MEG.0000000000002737
  12. Zhenzhen Yao, Yingping Gu, Xin Lai, Meng Yang, Yi Xu, Jiayou Luo, Songxu Peng. Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis. 2024
    https://doi.org/10.1093/infdis/jiae349
  13. Hye Won Lee, Seung Up Kim, Jun Yong Park, Oidov Baatarkhuu, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim. Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals. Clin Transl Gastroenterol 2019;10:e00036
    https://doi.org/10.14309/ctg.0000000000000036
  14. Norhidayah Abu, Noremylia Mohd Bakhori, Rafidah Hanim Shueb. Lateral Flow Assay for Hepatitis B Detection: A Review of Current and New Assays. Micromachines 2023;14:1239
    https://doi.org/10.3390/mi14061239
© Korean Society for Laboratory Medicine. / Powered by INFOrang Co., Ltd